Tumour cell-antibody interactions. II. In vitro studies
- PMID: 6977481
- PMCID: PMC1555266
Tumour cell-antibody interactions. II. In vitro studies
Abstract
The interaction of L5178Y thymic lymphoma cells syngeneic to DBA/2 mice and of normal thymocytes with goat IgG antibodies was studied in vitro. Viable tumour and normal cells exerted a rapid, continuous and temperature-dependent destruction of antibody activity. Fractionation studies of culture supernatants from antibody-coated cells revealed that a significant portion of the antibody was completely degraded to amino acids. Tumour cells digested antibody more effectively than did normal lymphocytes. This observed degradation of antibody was most extensive at 37 degrees, significantly less at room temperature (23 degrees) and not detectable at 0 degrees. Undegraded antibody released from antibody-coated cells had also lost its antibody activity to a considerable extent. This was due to the formation of soluble antigen-antibody complexes, which was observed even at 0 degrees. Cells fixed with 10% formalin bound maximum amounts of antibody were incapable of digesting antibody even at 37 degrees and did not release immune complexes. These findings are of relevance to cancer immunodiagnosis and immunotherapy.
Similar articles
-
Tumour cell-antibody interactions. I. In vivo experiments.Immunology. 1982 Feb;45(2):303-12. Immunology. 1982. PMID: 7061100 Free PMC article.
-
Novel tumor-specific antigen(s) response observed in a syngeneic lymphoma-bearing host.Cancer Detect Prev Suppl. 1987;1:111-20. Cancer Detect Prev Suppl. 1987. PMID: 3121177
-
Phenotypic shifts in the L5178Y lymphoma population during progression of the tumor-dormant state in DBA/2 mice.Cancer Res. 1984 Mar;44(3):1063-71. Cancer Res. 1984. PMID: 6607108
-
Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70.Eur J Immunol. 1990 Mar;20(3):629-36. doi: 10.1002/eji.1830200325. Eur J Immunol. 1990. PMID: 2318253
-
In vivo lysis of L5178Y cells in the establishment of the tumor-dormant state in DBA/2 mice.J Immunol. 1980 Apr;124(4):1642-7. J Immunol. 1980. PMID: 7365237 No abstract available.
Cited by
-
Immunoglobulins as targeting agents for liposome encapsulated drugs.Pharm Weekbl Sci. 1983 Dec 16;5(6):269-80. doi: 10.1007/BF02074854. Pharm Weekbl Sci. 1983. PMID: 6364035 Review.
-
Use of monoclonal antibodies and liposomes to improve drug delivery. Present status and future implications.Drugs. 1982 Oct;24(4):261-6. doi: 10.2165/00003495-198224040-00001. Drugs. 1982. PMID: 7140578 No abstract available.
-
Tumour cell-antibody interactions. I. In vivo experiments.Immunology. 1982 Feb;45(2):303-12. Immunology. 1982. PMID: 7061100 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources